Automated Insulin for Management of Intrapartum Glycemia
Start Date
12/5/2025
Completion Date
12/31/2028
Summary
The goal of this clinical trial is learn if automated insulin delivery (AID) systems can be used for glucose management during labor/delivery for pregnant people with type 1 diabetes (T1D). The main questions this study aims to answer are * What are the neonatal glycemic outcomes with use of AID systems during labor/delivery? * Do patients report higher birth satisfaction with use of AID systems during labor/delivery? * Are glycemic parameters like time-in-range (TIR) better with use of AID systems during labor/delivery? Researchers will compare AID systems to intravenous (IV) insulin (the current standard of care for glucose management during labor/delivery) by randomly assigning participants to one or the other.
Eligibility Criteria
Age Range: 18 years to 55 years
Interventions
Automated insulin delivery (AID) system
Intravenous (IV) insulin
Conditions
Locations
University of California, Los Angeles
Los Angeles, California 90095
United States
University of California, San Diego
San Diego, California 92121
United States
University of California, San Francisco
San Francisco, California 94143
United States